Medical Implants Market, By Product (Orthopedic implants (Reconstructive Joint Replacements, Orthobiologics, and Trauma & Craniomaxillofacial), Cardiovascular Implants (Pacing Devices), Stents (Coronary stents, Peripheral stents, Stent-related Implants), Structural Cardiac Implants (Mechanical Heart Valves, Implantable Ventricular-assist Devices, Spinal Implants, Neurostimulators), Opthalmic Implants , Dental Implants, Facial Implants, and Breast implants), By Biomaterial Type (Metallic Biomaterials, Ceramic Biomaterials, Polymers Biomaterials, and Natural Biomaterials), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Medical implants are medical devices that are placed inside or on the surface of the body. These implants can be placed permanently or they can be removed once they are no longer needed. For instance, stents or hip implants are intended to be permanent. While chemotherapy ports or screws to repair broken bones can be removed when they no longer needed.
Market Dynamics:
Increase in prevalence of chronic disease, growing geriatric (aging) population, increase in burden of musculoskeletal disorders, rise in adoption or demand for medical implants, and technological advancements are major factors expected to propel growth of the global medical implants market.
For instance, in February 2023, Maxon announced the launch of several new motors at MD&M West, including a series suitable for surgical robots and implants and a line of frameless DT motors with internal rotor technology.
Moreover, in March 2022, SurGenTec, a privately held spine and orthopedic technology company based in Florida, (US) received clearance from the U.S. Food and Drug Administration (FDA) for ION Screw, its proprietary stand-alone spine fixation implant.
Key features of the study:
This report provides in-depth analysis of the global medical implants market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global medical implants market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Biotronik, Inc., Livanova Plc, NuVasive, Inc., and Institut Straumann AG, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global medical implants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical implants market.